| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/14/2001 | EP1082307A1 Processes and intermediates for preparing 2-substituted piperidine stereoisomers |
| 03/14/2001 | EP1082303A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082294A1 Phenylalanine derivatives as integrin inhibitors |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082284A1 Condensation method for a carbonyl compound on an aromatic derivative in a basic medium |
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/14/2001 | EP1082121A1 Hiv integrase inhibitors |
| 03/14/2001 | EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/14/2001 | CN1287494A preventives / remedies for glaucoma |
| 03/14/2001 | CN1287117A Cycloene derivate, its producing process and its therapeutical use |
| 03/13/2001 | US6201133 Certain cyclic thio substituted acylaminoacid amide derivatives |
| 03/13/2001 | US6201025 For treatment of central nervous system disorders |
| 03/13/2001 | US6201024 Effective p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disorders |
| 03/13/2001 | US6201021 Pentanoic acid derivatives |
| 03/13/2001 | US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction |
| 03/13/2001 | US6201019 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 03/13/2001 | US6201013 Inosine monophosphate dehydrogenase (impdh) inhibitor; side effect reduction, non-drug resistant |
| 03/13/2001 | US6201007 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 03/13/2001 | US6200995 Pyridyloxybenzenesulfonamide derivatives; diabetes, obesity |
| 03/13/2001 | US6200993 Heterosubstituted pyridine derivatives as PDE4 inhibitors |
| 03/13/2001 | US6200987 Cyclic amides |
| 03/13/2001 | US6200982 Substituted 1H-pyridinyl-2-ones as GABAA-α 2/3 ligands |
| 03/13/2001 | US6200978 For preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, as analgesics |
| 03/13/2001 | US6200933 Low toxicity to humans and cattle |
| 03/13/2001 | US6200654 1,4-disubstituted 2,6-difluorobenzene compounds, and a liquid-crystalline medium |
| 03/08/2001 | WO2001016272A2 Ligand and complex for catalytically bleaching a substrate |
| 03/08/2001 | WO2001016271A1 Composition and method for bleaching a substrate |
| 03/08/2001 | WO2001016270A1 Composition and method for bleaching a substrate |
| 03/08/2001 | WO2001016269A1 Method of bleaching stained fabrics |
| 03/08/2001 | WO2001016268A1 Method of pretreating and bleaching stained fabrics |
| 03/08/2001 | WO2001016261A2 Composition and method for bleaching a substrate |
| 03/08/2001 | WO2001016131A2 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 03/08/2001 | WO2001016121A1 Heterocyclic compounds and methods of use thereof |
| 03/08/2001 | WO2001016107A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 03/08/2001 | WO2001016106A1 Benzamide formulation with histone deacetylase inhibitor activity |
| 03/08/2001 | WO2001016096A2 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 03/08/2001 | WO2001016094A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 03/08/2001 | WO2001016091A1 Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof |
| 03/08/2001 | WO2000062767A3 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion |
| 03/08/2001 | WO2000050872A3 A system for cell-based screening |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | WO1999058526A8 Novel 2,5-pyridinedicarboxylic acid derivatives |
| 03/08/2001 | WO1999039704A8 Antibacterial agents |
| 03/08/2001 | WO1999019296A8 Aminobutanoic acid derivatives |
| 03/08/2001 | DE19941656A1 New fluorothiophene, furan, isoxazole, thiazole, cyclopentane, cyclopentene and alkylfluorothiophenecarboxylic acid compounds are useful in liquid crystals mixtures and synthesis of liquid crystals, agrochemicals and pharmaceuticals |
| 03/08/2001 | DE19941540A1 New 2,4-disubstituted 5-sulfonyl-benzamides or analogs having LDL receptor inducing activity, useful for treating or preventing hyperlipidemia or arteriosclerosis |
| 03/08/2001 | CA2383935A1 Composition and method for bleaching a substrate |
| 03/08/2001 | CA2383783A1 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 03/08/2001 | CA2383781A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 03/08/2001 | CA2383695A1 Ligand and complex for catalytically bleaching a substrate |
| 03/08/2001 | CA2383596A1 Composition and method for bleaching a substrate |
| 03/08/2001 | CA2383590A1 Composition and method for bleaching a substrate |
| 03/08/2001 | CA2383307A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 03/08/2001 | CA2382115A1 Method of bleaching stained fabrics |
| 03/08/2001 | CA2382114A1 Method of pretreating and bleaching stained fabrics |
| 03/07/2001 | EP1081131A1 Selective anti-mycobacterial preparations, method for producing the same and pharmaceutical compositions |
| 03/07/2001 | EP1080105A1 Phenylalanine derivatives having vla-4 antagonistic activity |
| 03/07/2001 | EP1080086A1 Dihydropyrimidines |
| 03/07/2001 | EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080070A2 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 03/07/2001 | EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1079821A1 Protease inhibitors |
| 03/07/2001 | EP1079819A1 Hydroxamic acid derivatives as antibacterials |
| 03/07/2001 | CN1286684A Carboxamide derivs. of pyrrolidine, piperidine and hexahydroazepine for treatment of thrombosis disorders |
| 03/07/2001 | CN1286254A Aromatic amino ether as analgesics |
| 03/07/2001 | CN1062711C Pesticide and fungicide of unsaturated oximido ethers |
| 03/06/2001 | USRE37087 Insecticidal triffluormethyl alkane derivatives |
| 03/06/2001 | US6198011 Fluorinating chlorine containing organic compound comprising reacting in solvent reaction medium organic compound with alkali metal fluoride wherein solvent at least before reaction starts comprises perfluorocarbon |
| 03/06/2001 | US6197965 Polyarylalkylamino-substitued pyridine derivatives; drugs, medicine, diagnostics |
| 03/06/2001 | US6197964 Method for the production of 2,6-dichloro-5-fluoronicotinonitrile and the chemical compound 3-cyano-2-hydroxy-5-fluoropyride-6-one-monosodium salt its tautomers |
| 03/06/2001 | US6197962 Reacting a,b-unsaturated carbonyl compound with a sulfonyl cyanide; cyclization |
| 03/06/2001 | US6197961 Hydrogenation of g-(pyridyl)butyric acid salt in solvent using palladium, rhodium, or ruthenium catalyst; hydrolysis, decarboxylation |
| 03/06/2001 | US6197798 Inhibitors of microsomal triglyceride transfer protein |
| 03/06/2001 | US6197797 Cyanoguanidines as cell proliferation inhibitors |
| 03/06/2001 | US6197795 Antiarthritic agents; antitumor agents; wound healing agents |
| 03/06/2001 | US6197793 Hemoregulatory compounds |
| 03/06/2001 | US6197792 Tetra-substituted phenyl derivatives and processes for their preparation |
| 03/06/2001 | US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents |
| 03/06/2001 | US6197770 Alkenyl- and alkynl-containing metalloprotease inhibitors |
| 03/06/2001 | US6197716 As hydrogenation catalyst in hydrogenation of aromatic halonitro compounds to aromatic haloamino compounds |
| 03/06/2001 | CA2073673C Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors |
| 03/01/2001 | WO2001014391A1 Bisimidino compounds and the transitional metal complexes thereof as well as the use thereof as catalysts |
| 03/01/2001 | WO2001014376A1 Novel spiro compounds |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014355A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 03/01/2001 | WO2001014340A1 Agents for controlling animal diseases caused by endoparasites |
| 03/01/2001 | WO2001014339A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/01/2001 | WO2001014338A1 NOVEL INTEGRIN αVβ3 INHIBITORS |
| 03/01/2001 | WO2001014337A1 αvβ3 INTEGRIN INHIBITORS |
| 03/01/2001 | WO2001014336A1 Benzene derivatives substituted by aromatic ring and process for producing the same |
| 03/01/2001 | WO2001014334A1 Fluorenone compounds with modified 7-position substituents for treating and preventing brain and spinal injury |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014310A1 PLEUROMUTILIN β-KETOESTERS |
| 03/01/2001 | WO2001014299A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |